Dr. Olga Kubassova

Smart Imaging Strategy to Accelerate Drug Development
5c77eb91-3d58-4580-be24-929bb4b7f2a0

Dr. Olga Kubassova

Founder and President
Extensive expertise in identifying innovative approaches to clinical research, disruptive technology platforms and novel therapeutics.
Dr. Olga Kubassova is the founder and current President of Image Analysis Group (IAG), a position she has held since 2024 after serving as the company's CEO for over 15 years. She founded IAG shortly after completing her PhD, with the goal of commercializing her research and bringing innovative imaging solutions to clinical trials. Dr. Kubassova's background is in mathematics and computer science, with degrees from St. Petersburg State University, Lappeenranta University of Technology, and a PhD from the University of Leeds6. Her expertise lies in identifying innovative approaches to clinical research, disruptive technology platforms, and novel therapeutics. Under her leadership, IAG has grown into a global player in clinical development, providing advanced medical imaging and artificial intelligence solutions for drug development. The company has partnerships with top pharmaceutical companies, innovative biotech and medtech players, and maintains its own portfolio companies. Dr. Kubassova is also known for her commitment to supporting women in leadership positions, being a founding member of 'The 2% club'. Her vision for IAG continues to focus on leveraging technology and AI to optimize clinical trials and accelerate drug development.